The Transhumanist Agenda — Stated Openly
Transhumanism is the philosophical position that human biology is a limitation to be overcome through technology. Its adherents — now mainstream in Silicon Valley, academia, and corporate leadership — advocate for: genetic engineering of the human germline; brain-computer interfaces; nanoscale bioelectronic implants; life extension to functional immortality; and the eventual merger of human consciousness with artificial intelligence. This is not a fringe view. Ray Kurzweil — Google's Director of Engineering — has predicted the "Singularity" (merger of human and machine intelligence) for 2029. Klaus Schwab's The Fourth Industrial Revolution (2016) describes microchips embedded in human brains as a feature of the new economy. Yuval Harari's Homo Deus (2015) describes the "useless class" of humans who will be supplanted by augmented elites.
Neuralink — Brain-Computer Interface
Elon Musk's Neuralink received FDA approval for human trials in 2023 and implanted its first device in a human patient in January 2024. The device — the "N1 Implant" — embeds 1,024 electrodes in the brain cortex, wirelessly transmitting neural data. The stated application is paralysis treatment. The technical architecture is identical to what would be needed for bidirectional communication — not just reading neural data, but writing to it. DARPA's N3 programme (Next-Generation Non-Surgical Neurotechnology) has funded multiple parallel programmes since 2019, specifically for military personnel, with a goal of "direct neural control" of weapons systems.
Graphene Oxide — The Nanotech Question
Spanish researcher Ricardo Delgado (La Quinta Columna, 2021) published electron microscopy images of COVID-19 mRNA vaccine vials containing graphene oxide structures. Graphene oxide is highly conductive, biocompatible, and can self-assemble in biological environments at specific frequencies. The UK Medicines and Healthcare products Regulatory Authority (MHRA) refused Freedom of Information requests about the composition of vaccine adjuvants. Pablo Campra (University of Almería) published a peer-reviewed analysis (2021) confirming graphene-like structures in multiple vaccine products. Mainstream fact-checkers labelled this "debunked" without addressing the electron microscopy evidence directly.
DARPA Hydrogel and Biometric Surveillance
DARPA's Persistent Aqueous Activity Tracker (subdermal biosensor programme) developed a hydrogel implant — approved for use as a COVID-19 detection device — that monitors blood chemistry in real time through a subcutaneous sensor. The sensor communicates with external readers. The same hydrogel platform can monitor: glucose levels, oxygenation, electrolytes, inflammatory cytokines, and in future iterations, stress hormones and pharmaceutical blood levels. The patent trail connects the manufacturer (Profusa Inc.) to DARPA funding and NIH contracts. The device was featured in the New York Times as a "futuristic health monitoring breakthrough" with no mention of its military surveillance origins.
The WEF's Stated Goals Through 2030
"You will own nothing and you will be happy" — the 2016 WEF prediction for 2030 was initially framed as aspirational. The full document describes: end of private property ownership (replaced by subscription access); predictive consumption tracking through biometric data; AI-managed resource allocation; and a "new social contract" calibrated by digital behavioural scoring. The document was removed from the WEF website after widespread publication but is archived. The WEF's Young Global Leaders programme has placed alumni in: multiple cabinet positions across Western governments, heads of major news organisations, university vice-chancellorships, and WHO leadership.
The WHO Global Pandemic Treaty — Permanent Emergency Powers
The WHO's proposed amendments to the International Health Regulations, accepted by member states in 2024, create a framework in which any "public health emergency of international concern" — declared unilaterally by the WHO Director General — triggers mandatory compliance measures including vaccine mandates and border controls. The treaty requires member states to implement WHO directives within 48 hours. No parliamentary vote is required in signatory nations. Emergency powers, once granted, have historically never been fully returned. The regulatory architecture for permanent global biosurveillance and mandatory biometric technology adoption is now in place in treaty law.